ISPOR 19th ANNUAL INTERNATIONAL MEETING AWARDS WINNERS
 

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 20%, based on abstract review score, are considered and eligible for a poster presentation award.
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

THE RECIPIENTS  ARE: . . .

ISPOR Best Podium Research Presentation Awards

Best General Podium Presentations

MA2: NON-ADHERENCE TO ANTIPLATELET THERAPY AFTER HOSPITALIZATION FOR ACUTE CORONARY SYNDROME (ACS) INCREASES READMISSIONS, MORTALITY, HEALTH CARE USE AND COSTS
Hill J1, Pokras SM1, Makin C1, Schabert VF1, Nelson M2, Foody J3
1IMS Health, Plymouth Meeting, PA, USA, 2IMS Health, Alexandria, VA, USA, 3Brigham and Women’s Hospital, Boston, MA, USA

MO2: BENEFITS FROM INCORPORATING NETWORK META-ANALYSIS WITHIN STRATIFIED COST-EFFECTIVENESS ANALYSIS
Coyle D1, Coyle K2, Cameron C1, Lee KM3, Kelly S1, Steiner S4, Wells G5
1University of Ottawa, Ottawa, ON, Canada, 2Brunel University, Uxbridge, ON, Canada, 3Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada, 4Medical University Vienna, Vienna, Austria, 5University of Ottawa Heart Institute, Ottawa, ON, Canada

UT2: HEALTH STATE UTILITIES ASSOCIATED WITH ATTRIBUTES OF TREATMENTS FOR HEPATITIS C
Matza LS1, Sapra S2, Kalsekar A2, Dillon JF3, Davies E4, Devine MK1, Jordan J1, Landrian A1, Feeny DH5
1Evidera, Bethesda, MD, USA, 2Bristol-Myers Squibb, Princeton, NJ, USA, 3University of Dundee, Dundee, United Kingdom, 4Evidera, London, United Kingdom, 5University of Alberta, Portland, OR, USA


Best Student Podium Research Presentations

HC3: INCENTIVIZING VALUE IN MANAGED CARE DRUG FORMULARIES: DESIGN, IMPLEMENTATION, AND FIRST-YEAR OUTCOMES OF A VALUE-BASED FORMULARY
Watkins J1, Sullivan SD2, Yeung K3, Ramsey S4, Garrison L2, Wong E1, Murphy C1, Danielson D1, Veenstra DL3, Vogeler C1, Burke W5, McGee R1
1Premera Blue Cross, Mountlake Terrace, WA, USA, 2School of Pharmacy, University of Washington, Seattle, WA, USA, 3University of Washington, Seattle, WA, USA, 4Fred Hutchinson Cancer Research Center and Professor, Department of Medicine, University of Washington, Seattle, WA, USA, 5School of Medicine, University of Washington, Seattle, WA, USA

AH4: WILL THE AFFORDABLE CARE ACT (ACA) IMPROVE RACIAL/ETHNIC DISPARITY OF EYE EXAMINATION AMONG U.S. WORKING-AGE POPULATION WITH DIABETES?
Shi Q1, Fonseca V1, Zhao Y2, Krousel-Wood M1, Luo Q1, Shi L1
1Tulane University, New Orleans, LA, USA, 2College of Pharmacy, Xavier University of Louisiana, New Orleans, LA, USA

DB3: A SPATIAL DISTRIBUTION OF ADULT OBESITY PREVALENCE IN DENVER COUNTY, COLORADO: AN EMPIRICAL BAYES APPROACH
Tabano DC1, Barrow JC1, Daley MF2
1Kaiser Permanente, Denver, CO, USA, 2Kaiser Permanente Institute for Health Research, Denver, CO, USA

Best New Investigator Podium Research Presentations

HC2: THE IMPACT OF NICE'S END-OF-LIFE THRESHOLD ON PATIENT ACCESS TO NEW CANCER THERAPIES IN ENGLAND AND WALES
Stewart G, Eddowes L, Hamerslag L, Kusel J
Costello Medical Consulting Ltd., Cambridge, United Kingdom

MD4: REAL-WORLD COST EFFECTIVENESS OF THE MITRACLIP FOR THE TREATMENT OF HIGH-RISK MITRAL REGURGITATION
Asgar AW1, Khairy P1, Bernard L2, Cameron HL2, Ducharme A1, Guertin M1, Bonan R1, L'Allier P1, Tardif J1, Cohen D3
1Montreal Heart Institute, Montreal, QC, Canada, 2Cornerstone Research Group, Burlington, ON, Canada, 3Saint Lukes Hospital, Kansas City, KS, USA

DB4: THE APPLICATION OF NATURAL LANGUAGE PROCESSING (NLP) TECHNOLOGY TO ENRICH ELECTRONIC MEDICAL RECORDS (EMRS) FOR OUTCOMES RESEARCH IN ONCOLOGY
Hirst C1, Hill J2, Khosla S1, Schweikert K2, Senerchia C2, Kitzmann K2, Zhang Q1
1AstraZeneca, Macclesfield, United Kingdom, 2Humedica, Boston, MA, USA


ISPOR Best Poster Research Presentation Awards

Best General Poster Research Presentations

 

PMH34: THE BURDEN OF OPIOID ABUSE AMONG COMMERCIALLY-INSURED PATIENTS
Rice JB1, Kirson NY1, Shei A1, Enloe C1, Cummings AK1, Birnbaum HG1, Ben-Joseph R2
1Analysis Group, Inc., Boston, MA, USA, 2Purdue Pharma L.P., Stamford, CT, USA

 

PND29: HOSPITAL-BASED UTILIZATION IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME
Belk KW, Craver CW
MedAssets, Charlotte, NC, USA

PSY43: PSYCHOMETRIC PROPERTIES OF THE ADHD RATING SCALE-IV (ADHD RS-IV) AND ADULT ADHD SELF-REPORT SCALE (ASRS) IN A PHASE 3B CLINICAL TRIAL OF PATIENTS WITH PHENYLKETONURIA
Wyrwich KW1, Auguste P1, Yu R1, Zhang C2, Yu S2, DeWees B2, Winslow B2, Merilainen M2, Prasad S2
1Evidera, Bethesda, MD, USA, 2BioMarin Pharmaceutical Inc., Novato, CA, USA


Best Student Poster Research Presentations

PHP32: COMMUNITY PHARMACIST CHARACTERISTICS ASSOCIATED WITH USE OF A PRESCRIPTION DRUG MONITORING PROGRAM
Wixson SE, Blumenschein K, Goodin AJ, Talbert J, Freeman PR
University of Kentucky, Lexington, KY, USA

PHP42: TRENDS IN MEDICAID FEE-FOR-SERVICE OUTPATIENT DRUG UTILIZATION, EXPENDITURES AND PHARMACY REIMBURSEMENT RATES (2010-2012)
Balkhi B1, Alshehri A1, Szeinbach SL2, Seoane-Vazquez E1
1International Center for Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA, 2Ohio State University, Columbus, OH, USA
PHS29: ASSESSING THE ECONOMIC BURDEN OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER AMONG CHILDREN IN THE UNITED STATES USING THE 2011 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Gupte KP, Singh RR, Lawson KA
The University of Texas at Austin, Austin, TX, USA

Best New Investigator Poster Research Presentations

PHS51: COST-EFFECTIVENESS ANALYSIS OF GOVERNMENT INSURED ROUTINE EYE EXAMINATION: EVIDENCE FROM PRINCE EDWARDS ISLAND, CANADA
Thavorn K1, Tu HA2, Wedge R3, Jin Y2, Trope G2, El-Defrawy S4, Flanagan J5, Buys YM2
1St.Michael's Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Health PEI, Charlottetown, PE, Canada, 4Kensington Eye Institute, Toronto, ON, Canada, 5University of Toronto, ON, Canada
PRM78: A COMPARISON OF THE UTILITY OF VARIANTS OF THE CHARLSON COMORBIDITY INDEX (CCI) IN PREDICTING PATIENT-REPORTED HEALTH OUTCOMES
Witt EA1, Goren A2
1Kantar Health, Princeton, NJ, USA, 2Kantar Health, New York, NY, USA
PHS119: PROVISION OF CULTURAL COMPETENCY TRAINING IN THE NATIONAL HOME AND HOSPICE CARE SURVEY: THE ROLE OF ORGANIZATIONAL AND LEADERSHIP FACTORS
AbuDagga A1, Khasawinah S2, Weech-Maldonado R3, Tian F4
1Public Citizen, Washington DC, DC, USA, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, DC, USA, 3University of Alabama at Birmingham, Birmingham, AL, USA, 4HealthCore Inc., Alexandria, VA, USA

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.

 

Return to ISPOR Awards Index Page